propranolol has been researched along with Benign Neoplasms in 37 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol treatment produced slight and similar effects in both normal and tumour-bearing rats." | 5.26 | Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma. ( Debreczeni, LA; Farsang, C; Takács, L, 1980) |
| "The serendipitous demonstration that the nonselective β-adrenergic receptor (β-AR) antagonist propranolol promotes the regression of infantile hemangiomas (IHs) aroused interest around the involvement of the β-adrenergic system in angiogenic processes." | 4.91 | Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. ( Bagnoli, P; Casini, G; Dal Monte, M; Daniotti, M; Filippi, L; Sereni, F, 2015) |
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| " The beta-blocker propranolol, known for its effectiveness on cutaneous hemangiomas, is also proving useful for the treatment of subglottic or visceral hemangiomas." | 3.78 | [Pediatrics]. ( Chevallay, M; de Buys Roessingh, A; El Ezzi, O; Fischer, CJ; Gehri, M; Giannoni, E; Hauschild, M; Hohlfeld, J; Pauchard, JY; Seneggen, E; Tolsa, JF; Truttmann, AC, 2012) |
| "Propranolol was convenient and safe in fasting adolescent and young adult oncology patients undergoing PET scans." | 2.84 | Pilot study of propranolol premedication to reduce FDG uptake in brown adipose tissue on PET scans of adolescent and young adult oncology patients. ( Conrad, G; Dressler, EV; George, A; Memon, AA; Sinha, P; Wagner, LM, 2017) |
| "In both cancer and embryo, β3-ARs exert similar functions by exploiting a metabolic shift known as the Warburg effect, by acquiring resistance against xenobiotics, and by inducing a local immune tolerance." | 2.82 | β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo. ( Bagnoli, P; Cammalleri, M; Dal Monte, M; Filippi, L; Pini, A, 2022) |
| " This study demonstrates that autonomic nervous system dysfunction occurs and is responsible for the elevated BMR in elderly cancer patients, propranolol administration rectifies the autonomic dysfunction, and Intralipid infusion combined with propranolol administration is useful for enhancing the daily caloric intake without a strong increase in energy expenditure." | 2.69 | Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients. ( Gambardella, A; Paolisso, G; Pesce, L; Tagliamonte, MR; Tortoriello, R; Varricchio, M, 1999) |
| "Atenolol treatment reduced REE by 77+/-14 kcal/day and propranolol by 48+/-13 kcal/day, respectively (P<0." | 2.69 | Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. ( Daneryd, P; Hyltander, A; Körner, U; Lundholm, K; Sandström, R, 2000) |
| "Propranolol treatment was associated with a significant reduction in plasma concentrations of free fatty acids (FFA), but not in plasma glycerol." | 2.67 | Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. ( Hyltander, A; Körner, U; Lundholm, KG, 1993) |
| "Airway tumors are rare in children." | 1.91 | Rare airway tumor in a previously healthy adolescent successfully treated with endoscopic resection and oral propranolol. ( Gipsman, AI; Piccione, J; Treat, JR, 2023) |
| "When tumors reached 100 mm, mice were treated with CpG-C/vehicle, and 24 hours later the tumor was excised along with P+E/vehicle treatment." | 1.37 | Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. ( Ben-Eliyahu, S; Benish, M; Goldfarb, Y; Levi, B; Melamed, R; Sorski, L, 2011) |
| "Twenty-six cancer patients, presenting with increased BAT FDG uptake, were selected prospectively." | 1.34 | Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. ( Gerbaudo, VH; Jager, V; Mollerach, AM; Parysow, O; Racioppi, S; San Roman, J, 2007) |
| " On the contrary, the chronic administration of corticosterone significantly induced the atrophy of thymus and spleen without affecting tumor growth." | 1.31 | Psychosocial stress augments tumor development through beta-adrenergic activation in mice. ( Hasegawa, H; Saiki, I, 2002) |
| "Propranolol treatment produced slight and similar effects in both normal and tumour-bearing rats." | 1.26 | Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma. ( Debreczeni, LA; Farsang, C; Takács, L, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (18.92) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 13 (35.14) | 24.3611 |
| 2020's | 7 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| La Regina, G | 1 |
| Bai, R | 1 |
| Coluccia, A | 1 |
| Famiglini, V | 1 |
| Pelliccia, S | 1 |
| Passacantilli, S | 1 |
| Mazzoccoli, C | 1 |
| Ruggieri, V | 1 |
| Verrico, A | 1 |
| Miele, A | 1 |
| Monti, L | 1 |
| Nalli, M | 1 |
| Alfonsi, R | 1 |
| Di Marcotullio, L | 1 |
| Gulino, A | 1 |
| Ricci, B | 1 |
| Soriani, A | 1 |
| Santoni, A | 1 |
| Caraglia, M | 1 |
| Porto, S | 1 |
| Da Pozzo, E | 1 |
| Martini, C | 1 |
| Brancale, A | 1 |
| Marinelli, L | 1 |
| Novellino, E | 1 |
| Vultaggio, S | 1 |
| Varasi, M | 1 |
| Mercurio, C | 1 |
| Bigogno, C | 1 |
| Dondio, G | 1 |
| Hamel, E | 1 |
| Lavia, P | 1 |
| Silvestri, R | 1 |
| Unzue, A | 1 |
| Lafleur, K | 1 |
| Zhao, H | 1 |
| Zhou, T | 1 |
| Dong, J | 1 |
| Kolb, P | 1 |
| Liebl, J | 1 |
| Zahler, S | 1 |
| Caflisch, A | 1 |
| Nevado, C | 1 |
| Beaufils, F | 1 |
| Cmiljanovic, N | 1 |
| Cmiljanovic, V | 1 |
| Bohnacker, T | 1 |
| Melone, A | 1 |
| Marone, R | 1 |
| Jackson, E | 1 |
| Zhang, X | 1 |
| Sele, A | 1 |
| Borsari, C | 1 |
| Mestan, J | 1 |
| Hebeisen, P | 1 |
| Hillmann, P | 1 |
| Giese, B | 1 |
| Zvelebil, M | 1 |
| Fabbro, D | 1 |
| Williams, RL | 1 |
| Rageot, D | 1 |
| Wymann, MP | 1 |
| Filippi, L | 2 |
| Pini, A | 1 |
| Cammalleri, M | 1 |
| Bagnoli, P | 2 |
| Dal Monte, M | 2 |
| Fjæstad, KY | 1 |
| Rømer, AMA | 1 |
| Goitea, V | 1 |
| Johansen, AZ | 1 |
| Thorseth, ML | 1 |
| Carretta, M | 1 |
| Engelholm, LH | 1 |
| Grøntved, L | 1 |
| Junker, N | 1 |
| Madsen, DH | 1 |
| Yang, C | 1 |
| He, Y | 1 |
| Chen, F | 1 |
| Zhang, F | 1 |
| Shao, D | 1 |
| Wang, Z | 1 |
| Ammons, DT | 1 |
| MacDonald, CR | 1 |
| Chow, L | 1 |
| Repasky, EA | 1 |
| Dow, S | 1 |
| Gipsman, AI | 1 |
| Treat, JR | 1 |
| Piccione, J | 1 |
| Puzderova, B | 1 |
| Belvoncikova, P | 1 |
| Grossmannova, K | 1 |
| Csaderova, L | 1 |
| Labudova, M | 1 |
| Fecikova, S | 1 |
| Pastorek, J | 1 |
| Barathova, M | 1 |
| Brady, SL | 1 |
| Wong, KK | 1 |
| Doubrovin, M | 1 |
| Han, Y | 1 |
| Li, Y | 1 |
| Wu, S | 1 |
| Hossain, AKMM | 1 |
| Chism, CB | 1 |
| Naik, MH | 1 |
| Rossi, M | 1 |
| Shulkin, BL | 1 |
| George, A | 1 |
| Sinha, P | 1 |
| Conrad, G | 1 |
| Memon, AA | 1 |
| Dressler, EV | 1 |
| Wagner, LM | 1 |
| Wang, H | 1 |
| Gomez, DR | 1 |
| Liao, Z | 1 |
| Shaughnessy, R | 1 |
| Retamal, C | 1 |
| Oyanadel, C | 1 |
| Norambuena, A | 1 |
| López, A | 1 |
| Bravo-Zehnder, M | 1 |
| Montecino, FJ | 1 |
| Metz, C | 1 |
| Soza, A | 1 |
| González, A | 1 |
| Casini, G | 1 |
| Daniotti, M | 1 |
| Sereni, F | 1 |
| Chang, PY | 1 |
| Huang, WY | 1 |
| Lin, CL | 1 |
| Huang, TC | 1 |
| Wu, YY | 1 |
| Chen, JH | 1 |
| Kao, CH | 1 |
| Duff, S | 1 |
| Connolly, C | 1 |
| Buggy, DJ | 1 |
| Agrawal, A | 1 |
| Nair, N | 1 |
| Baghel, NS | 1 |
| Friedman, GD | 1 |
| Udaltsova, N | 1 |
| Habel, LA | 1 |
| Schuller, HM | 1 |
| Goldfarb, Y | 1 |
| Sorski, L | 1 |
| Benish, M | 1 |
| Levi, B | 1 |
| Melamed, R | 1 |
| Ben-Eliyahu, S | 1 |
| Fischer, CJ | 1 |
| Giannoni, E | 1 |
| Truttmann, AC | 1 |
| Tolsa, JF | 1 |
| Chevallay, M | 1 |
| El Ezzi, O | 1 |
| Seneggen, E | 1 |
| Hohlfeld, J | 1 |
| de Buys Roessingh, A | 1 |
| Pauchard, JY | 1 |
| Gehri, M | 1 |
| Hauschild, M | 1 |
| Hasegawa, H | 1 |
| Saiki, I | 1 |
| TUCKER, MJ | 1 |
| ALCOCK, SJ | 1 |
| BAKER, SB | 1 |
| Söderlund, V | 1 |
| Larsson, SA | 1 |
| Jacobsson, H | 1 |
| Parysow, O | 1 |
| Mollerach, AM | 1 |
| Jager, V | 1 |
| Racioppi, S | 1 |
| San Roman, J | 1 |
| Gerbaudo, VH | 1 |
| Abramson, FP | 1 |
| Jenkins, J | 1 |
| Ostchega, Y | 1 |
| Debreczeni, LA | 1 |
| Farsang, C | 1 |
| Takács, L | 1 |
| Hyltander, A | 2 |
| Körner, U | 2 |
| Lundholm, KG | 1 |
| Gambardella, A | 1 |
| Tortoriello, R | 1 |
| Pesce, L | 1 |
| Tagliamonte, MR | 1 |
| Paolisso, G | 1 |
| Varricchio, M | 1 |
| Daneryd, P | 1 |
| Sandström, R | 1 |
| Lundholm, K | 1 |
| Noori, A | 1 |
| Lindenfeld, J | 1 |
| Wolfel, E | 1 |
| Ferguson, D | 1 |
| Bristow, MR | 1 |
| Lowes, BD | 1 |
| Frishman, W | 1 |
| Silverman, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Jusko, WJ | 1 |
| Gretch, M | 1 |
| Sieber, SM | 1 |
| Adamson, RA | 1 |
| Pimm, MV | 1 |
| Conway, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Improving Perioperative Pain Management for Laparoscopic Surgery Due to Colon Cancer Using the Ultrasound-guided Transmuscular Quadratus Lumborum Block. A Double Blind, Randomized, Placebo Controlled Trial.[NCT03570541] | Phase 4 | 69 participants (Actual) | Interventional | 2018-06-28 | Completed | ||
| Anesthesia and Immunological and Oxidative Stress in Relation to Abdominal Cancer Surgery[NCT03974984] | 0 participants (Actual) | Observational | 2020-06-04 | Withdrawn (stopped due to Not feasable due to logistics) | |||
| Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery[NCT04860115] | 120 participants (Anticipated) | Interventional | 2021-11-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for propranolol and Benign Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation.
Topics: Animals; Computer Simulation; Drug Design; Humans; Isoquinolines; Neoplasms; Protein Kinase Inhibito | 2016 |
β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.
Topics: Humans; Infant, Newborn; Infant, Newborn, Diseases; Neoplasms; Propranolol; Receptors, Adrenergic; R | 2022 |
Chronic adrenergic stress and generation of myeloid-derived suppressor cells: Implications for cancer immunotherapy in dogs.
Topics: Adrenergic Agents; Animals; Dog Diseases; Dogs; Humans; Immunotherapy; Mice; Myeloid-Derived Suppres | 2023 |
Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Child, Preschool; Hemangioma; Humans; Hypoxi | 2015 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Adrenergic, Inflammatory, and Immune Function in the Setting of Oncological Surgery: Their Effects on Cancer Progression and the Role of the Anesthetic Technique in their Modulation.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Disease Models, Animal; Disease Progr | 2016 |
Plasma and tissue protein binding of drugs in pharmacokinetics.
Topics: Adrenal Cortex Hormones; Age Factors; Aging; Albumins; Animals; Anti-Bacterial Agents; Antibodies; A | 1976 |
4 trials available for propranolol and Benign Neoplasms
| Article | Year |
|---|---|
Pilot study of propranolol premedication to reduce FDG uptake in brown adipose tissue on PET scans of adolescent and young adult oncology patients.
Topics: Adipose Tissue, Brown; Adolescent; Adult; Blood Glucose; Blood Pressure; Female; Fluorodeoxyglucose | 2017 |
Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours.
Topics: Basal Metabolism; Energy Metabolism; Female; Hormones; Humans; Indomethacin; Male; Morphine; Neoplas | 1993 |
Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients.
Topics: Adrenergic beta-Antagonists; Aged; Basal Metabolism; Cachexia; Calorimetry, Indirect; Catecholamines | 1999 |
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Cachexia; Calorimetry, Indirect; Carbohydrate Metabolism; Ene | 2000 |
26 other studies available for propranolol and Benign Neoplasms
| Article | Year |
|---|---|
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.
Topics: Animals; Cell Division; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Hedg | 2015 |
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
Topics: Administration, Oral; Aminopyridines; Animals; Antineoplastic Agents; Brain; Cell Proliferation; Dog | 2017 |
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment.
Topics: Adrenergic beta-Antagonists; Animals; Immune Checkpoint Inhibitors; Mice; Neoplasms; Propranolol; Tu | 2022 |
Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine.
Topics: Animals; Biomimetics; Cancer Vaccines; Dendritic Cells; Immunotherapy; Mice; Mice, Inbred C57BL; Nan | 2023 |
Rare airway tumor in a previously healthy adolescent successfully treated with endoscopic resection and oral propranolol.
Topics: Adolescent; Adult; Child; Female; Granuloma, Pyogenic; Hemoptysis; Humans; Neoplasms; Propranolol; T | 2023 |
Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase IX; Cell Line, Tumor; Fluorouracil; Humans; Mice; Ne | 2023 |
Effect of Propranolol on 18F-Fluorodeoxyglucose Uptake in Brown Adipose Tissue in Children and Young Adults with Neoplastic Diseases.
Topics: Adipose Tissue, Brown; Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Child; Child, | 2021 |
β-Blockers and metastasis in non-small-cell lung cancer.
Topics: Adrenergic beta-Antagonists; Animals; Carcinoma, Non-Small-Cell Lung; gamma-Aminobutyric Acid; Human | 2013 |
Epidermal growth factor receptor endocytic traffic perturbation by phosphatidate phosphohydrolase inhibition: new strategy against cancer.
Topics: Desipramine; Endocytosis; Endosomes; Enzyme Inhibitors; ErbB Receptors; HeLa Cells; Humans; Ligands; | 2014 |
Propranolol Reduces Cancer Risk: A Population-Based Cohort Study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiovascular Diseases; Comorbidity; Female; Humans; Inci | 2015 |
A novel approach for reduction of brown fat uptake on FDG PET.
Topics: Adipose Tissue, Brown; Adolescent; Adrenergic beta-Antagonists; Adult; Female; Fluorodeoxyglucose F1 | 2009 |
Norepinephrine antagonists and cancer risk.
Topics: Atenolol; Breast Neoplasms; Clonidine; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Meto | 2011 |
Beta-adrenergic signaling, a novel target for cancer therapy?
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Hyp | 2010 |
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Topics: Analysis of Variance; Animals; Chemotherapy, Adjuvant; Disease Models, Animal; Etodolac; Female; Imm | 2011 |
[Pediatrics].
Topics: Adrenergic beta-Agonists; Bacterial Infections; Breast Feeding; Enterocolitis, Necrotizing; Fever; G | 2012 |
Psychosocial stress augments tumor development through beta-adrenergic activation in mice.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Cell Division; | 2002 |
ABSENCE OF CARCINOGENIC PROPERTIES OF PROPRANOLOL IN MICE.
Topics: Animals; Carcinogens; Neoplasms; Neoplasms, Experimental; Pharmacology; Propranolol; Research; Sympa | 1965 |
Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol.
Topics: Adipose Tissue, Brown; Adult; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; | 2007 |
Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans.
Topics: Adipose Tissue; Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Cohort Studies | 2007 |
Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.
Topics: Adolescent; Adult; Aged; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms; Orosomucoid; Pro | 1982 |
Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma.
Topics: Animals; Axilla; Blood Circulation; Blood Pressure; Carcinoma; Cardiac Output; Humans; Hyperkinesis; | 1980 |
Beta-blockade in adriamycin-induced cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antineoplastic Agents; Carbazoles; Cardiomyopathies; Cardi | 2000 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Letter: Selection of carriers for alkylating moieties to increase their antitumor specificity.
Topics: Alkylating Agents; Animals; Biopharmaceutics; Chemical Phenomena; Chemistry; Humans; Methoxsalen; Ne | 1976 |
An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.
Topics: Animals; Antibodies, Monoclonal; Humans; Mice; Mice, Nude; Neoplasms; Osteosarcoma; Pindolol; Propra | 1990 |
Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Diuretics; Humans; Hyperaldosteronism; Hype | 1973 |